z-logo
open-access-imgOpen Access
Ultra Low Dose Delta 9-Tetrahydrocannabinol Protects Mouse Liver from Ischemia Reperfusion Injury
Author(s) -
Edith Hochhauser,
Eylon Lahat,
Maya Sultan,
Orit Pappo,
Maayan Waldman,
Yosef Sarne,
Asher Shainberg,
Mordechai Gutman,
Michal Safran,
Ziv Ben Ari
Publication year - 2015
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000430165
Subject(s) - pharmacology , oxidative stress , reperfusion injury , medicine , liver injury , tunel assay , proinflammatory cytokine , ischemia , apoptosis , cannabinoid , endocrinology , chemistry , inflammation , receptor , biochemistry , immunohistochemistry
Ischemia/reperfusion (I/R) injury is the main cause of both primary graft dysfunction and primary non-function of liver allografts. Cannabinoids has been reported to attenuate myocardial, cerebral and hepatic I/R oxidative injury. Delta-9-tetrahydrocannabinol (THC), a cannabinoid agonist, is the active components of marijuana. In this study we examined the role of ultralow dose THC (0.002mg/kg) in the protection of livers from I/R injury. This extremely low dose of THC was previously found by us to protect the mice brain and heart from a variety of insults.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom